Generate a tailored SOP for Dr. Kate Weeks. Improve your application with a focused, well-structured draft.
Kate Weeks leads the Molecular Cardiology Group at the Baker Institute, utilizing in vivo mouse models, cell culture systems, and molecular biology approaches alongside state-of-the-art omic technologies to characterize novel signaling mechanisms that contribute to cardiac remodeling and heart failure. Her current research focuses on group enzymes, specifically protein phosphatase regulatory subunits that control phosphatase activity and function in the context of cardiac remodeling and heart disease. The findings from her research aim to inform the development and translation of new therapies for heart failure. Kate was awarded her PhD in Biochemistry and Molecular Biology from the University of Melbourne in 2012. Following this, she received a competitive Overseas Research Fellowship from the Heart Foundation to undertake postdoctoral training at King's College London under the mentorship of Prof. Metin Avkiran. In 2018, Kate was honored with the Emerging Leader Fellowship from the Baker Institute and the Shine Foundation, establishing the Molecular Cardiology Group. Her current research is supported by the Future Leader Fellowship from the Heart Foundation, along with project grants from the Shine Foundation and Diabetes Australia. Her expertise aligns with the UN Sustainable Development Goals set in 2015.
Monash University • Melbourne, VIC, Australia
Adjunct lecturer involved in teaching and research in molecular cardiology.
Requirements are standardized across the Faculty of Information Technology for most Master's programs including Computer Science and Data Science.